OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Breast Cancer Stem Cell State Equilibrium through Modulation of Redox Signaling
Ming Luo, Shang Li, Michael Brooks, et al.
Cell Metabolism (2018) Vol. 28, Iss. 1, pp. 69-86.e6
Open Access | Times Cited: 326

Showing 1-25 of 326 citing articles:

Oxidative Stress in Cancer
John D. Hayes, Albena T. Dinkova‐Kostova, Kenneth D. Tew
Cancer Cell (2020) Vol. 38, Iss. 2, pp. 167-197
Open Access | Times Cited: 1839

Modulating ROS to overcome multidrug resistance in cancer
Qingbin Cui, Jing‐Quan Wang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2018) Vol. 41, pp. 1-25
Closed Access | Times Cited: 560

The Complex Interplay between Antioxidants and ROS in Cancer
Isaac S. Harris, Gina M. DeNicola
Trends in Cell Biology (2020) Vol. 30, Iss. 6, pp. 440-451
Closed Access | Times Cited: 492

Metabolic heterogeneity confers differences in melanoma metastatic potential
Alpaslan Tasdogan, Brandon Faubert, Vijayashree Ramesh, et al.
Nature (2019) Vol. 577, Iss. 7788, pp. 115-120
Open Access | Times Cited: 404

Cancer stem cell (CSC) resistance drivers
Masoud Najafi, Keywan Mortezaee, Jamal Majidpoor
Life Sciences (2019) Vol. 234, pp. 116781-116781
Closed Access | Times Cited: 379

Hybrid epithelial/mesenchymal phenotypes promote metastasis and therapy resistance across carcinomas
Mohit Kumar Jolly, Jason A. Somarelli, Maya U. Sheth, et al.
Pharmacology & Therapeutics (2018) Vol. 194, pp. 161-184
Open Access | Times Cited: 288

The Warburg metabolism fuels tumor metastasis
Jianrong Lu
Cancer and Metastasis Reviews (2019) Vol. 38, Iss. 1-2, pp. 157-164
Closed Access | Times Cited: 178

CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer
María Auxiliadora Olivares‐Urbano, Carmen Griñán‐Lisón, Juan Antonio Marchal, et al.
Cells (2020) Vol. 9, Iss. 7, pp. 1651-1651
Open Access | Times Cited: 177

Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
So‐Yeon Park, Jang‐Hyun Choi, Jeong‐Seok Nam
Cancers (2019) Vol. 11, Iss. 7, pp. 965-965
Open Access | Times Cited: 150

Reactive oxygen species: Role in carcinogenesis, cancer cell signaling and tumor progression
Fabiola Lilí Sarmiento-Salinas, Andrea Perez-Gonzalez, Adilene Acosta-Casique, et al.
Life Sciences (2021) Vol. 284, pp. 119942-119942
Closed Access | Times Cited: 143

LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack
Jaganathan Venkatesh, Marie‐Claire D. Wasson, Justin M. Brown, et al.
Cancer Letters (2021) Vol. 509, pp. 81-88
Open Access | Times Cited: 136

Glucose Metabolism and Glucose Transporters in Breast Cancer
Eunah Shin, Ja Seung Koo
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 120

Targeting ROS in cancer: rationale and strategies
Christophe Glorieux, Shihua Liu, Dunyaporn Trachootham, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 8, pp. 583-606
Closed Access | Times Cited: 120

Targeting Breast Cancer Stem Cells
Lu Zhang, Wen‐Ming Chen, Suling Liu, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 2, pp. 552-570
Open Access | Times Cited: 112

Metabolic reprogramming in renal cancer: Events of a metabolic disease
Samik Chakraborty, Murugabaskar Balan, Akash Sabarwal, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 1, pp. 188559-188559
Open Access | Times Cited: 111

Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities
Zhao Huang, Zhe Zhang, Chengwei Zhou, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 94

Novel Insights on the Use of L-Asparaginase as an Efficient and Safe Anti-Cancer Therapy
Maaike Van Trimpont, Evelien Peeters, Yanti De Visser, et al.
Cancers (2022) Vol. 14, Iss. 4, pp. 902-902
Open Access | Times Cited: 80

Reactive Oxygen Species Bridge the Gap between Chronic Inflammation and Tumor Development
Weihua Yu, Yongmei Tu, Zi Long, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-22
Open Access | Times Cited: 76

Hallmarks of cancer stemness
Jia-Jian Loh, Stephanie Ma
Cell stem cell (2024) Vol. 31, Iss. 5, pp. 617-639
Closed Access | Times Cited: 63

Targeting Microglial Metabolic Rewiring Synergizes with Immune-Checkpoint Blockade Therapy for Glioblastoma
Zengpanpan Ye, Xiaolin Ai, Kailin Yang, et al.
Cancer Discovery (2023) Vol. 13, Iss. 4, pp. 974-1001
Open Access | Times Cited: 47

Roles of reactive oxygen species in inflammation and cancer
Yunfei Yu, Shengzhuo Liu, Luchen Yang, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 30

The Multifaceted Roles of NRF2 in Cancer: Friend or Foe?
Christophe Glorieux, Cinthya Enríquez, Constanza Díaz González, et al.
Antioxidants (2024) Vol. 13, Iss. 1, pp. 70-70
Open Access | Times Cited: 29

Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases
Bowen Yang, Yumeng Lin, Yibo Huang, et al.
Redox Biology (2024) Vol. 70, pp. 103032-103032
Open Access | Times Cited: 21

ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2
Maowu Luo, Lei Bao, Yuanyuan Xue, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 6
Open Access | Times Cited: 21

Page 1 - Next Page

Scroll to top